首页> 美国卫生研究院文献>Journal of Virology >Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
【2h】

Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

机译:新型人类冠状病毒中东呼吸综合征冠状病毒S蛋白的受体结合域的鉴定作为疫苗开发的基本目标。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A novel human Middle East respiratory syndrome coronavirus (MERS-CoV) caused outbreaks of severe acute respiratory syndrome (SARS)-like illness with a high mortality rate, raising concerns of its pandemic potential. Dipeptidyl peptidase-4 (DPP4) was recently identified as its receptor. Here we showed that residues 377 to 662 in the S protein of MERS-CoV specifically bound to DPP4-expressing cells and soluble DPP4 protein and induced significant neutralizing antibody responses, suggesting that this region contains the receptor-binding domain (RBD), which has a potential to be developed as a MERS-CoV vaccine.
机译:一种新型的人类中东呼吸综合症冠状病毒(MERS-CoV)导致高死亡率的严重急性呼吸综合症(SARS)样疾病暴发,引起人们对其大流行潜力的关注。二肽基肽酶-4(DPP4)最近被确定为其受体。在这里,我们显示MERS-CoV S蛋白中的残基377至662与表达DPP4的细胞和可溶性DPP4蛋白特异性结合,并诱导了显着的中和抗体反应,表明该区域包含受体结合域(RBD),该区域具有有可能被开发为MERS-CoV疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号